The global catheters market is projected to reach USD 24.2 billion by 2025 from USD 15.9 billion in 2020, at a CAGR of 8.7%. The demand for catheters is majorly driven by the growth in the target patient population and the rising focus on minimally invasive surgical procedures over conventional surgery. However, product failures and recalls, unfavorable taxation policies, and trade barriers are expected to restrain the growth of this market during the forecast period.
The electrophysiology catheters segment held the largest share of the cardiovascular catheters market in 2019
Based on type, the cardiovascular catheters segment is categorized into angiography catheters, IVUS/OCT catheters, guiding catheters, electrophysiology catheters, and balloon catheters. In 2019, electrophysiology catheters held the largest share of the cardiovascular market. This is primarily attributed to the high prevalence of atrial fibrillation (AF) and the rising geriatric population.
The hospitals segment is expected to register the highest CAGR in the catheters end-user market in 2019.
On the basis of end user, the catheters market is segmented into hospitals, long-term care facilities, diagnostic imaging centers, and other end users. In 2019, hospitals accounted for the largest share of the market. This segment is also expected to grow at the highest CAGR during the forecast period. The large share and high CAGR of this segment are attributed to factors such as the rising prevalence of CVD, urinary incontinence, and other chronic diseases, and the subsequent increase in the number of patients across the globe, leading to a growing demand for hospital treatment.
North America was the largest regional market for catheters market in 2019.
The market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America was the largest market segment, followed by Europe. This is attributed to the large number of target procedures performed in the region, the presence of a well-established healthcare system, and investments by hospitals to upgrade & expand operating capabilities. While growth in the US and European markets for catheters is reaching stagnancy due to market saturation, the market in the APAC is expected to witness significant growth in the coming years. This market segment is expected to register the highest CAGR during the forecast period due to favorable regulatory guidelines and government support, lower manufacturing costs, the growing presence of market players in emerging economies, and constant growth in healthcare expenditure.
Key Market Players
Players operating in this market include Medtronic (Ireland), Teleflex Incorporated (US), Abbott (US), B. Braun Melsungen AG (Germany), Edwards Lifesciences Corporation (US), Coloplast (Denmark), Johnson & Johnson Services (US), Terumo Corporation (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), ConvaTec Group (UK), Hollister Incorporated (US), Stryker (US), Cook Medical (US), and Merit Medical Systems (US).
Becton, Dickinson and Company (BD) (US) was one of the leading players in the intravenous market in 2018. This can be attributed to its robust product portfolio and strong geographic presence. To maintain its leadership, BD focuses on developing new products. BD’s products are manufactured and sold across the globe. Its products are marketed in the US and internationally through direct sales and independent distribution channels.
This report categorizes the market into the following segments and subsegments: